Moderna stock surges as melanoma vaccine trial shows "landmark moment" Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer. cbsnews.com cbsnews.com / feeds cbsnews-com .. cbsnews-com-health / / #news / / 24 days 24d Share
